A new device that has the potential to offer physicians the ability to more efficiently and effectively manage the individualized needs of patients with heart failure is now being used at Saint John’s Health Center in Santa Monica.

Developed by St. Jude Medical and successfully used by Dr. Shephal Doshi, director of electrophysiology and pacing at Saint John’s, the Unify Quadra CRT-D cardiac resynchronization therapy defibrillator can reduce the need for reoperation, according to Saint John’s.

The device received U.S. Food and Drug Administration (FDA) approval Nov. 29, and Saint John’s began offering the device hospital-wide following FDA approval on Jan. 1.

“This technology is the industry’s first quadripolar pacing system, and we are excited to be among the first hospitals in the country to implant this state-of-the-art device,” said Doshi. “By continuing our efforts to provide patients access to smart technologies such as Unify Quadra, we can further enhance their quality of life.”

The instrument is designed to optimize the heart’s pumping function and help it perform in its most natural state by synchronizing the left and right ventricles of the heart through timed electrical pulses, according to a hospital spokesman.

Share